Affiliation:
1. Center for Drug Research and Development, Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, Washington, DC, United States
Abstract
Breast cancer therapy involves a multidisciplinary approach comprising
surgery, radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of
breast cancer requires maximum therapeutic efficacy, with minimal undesirable effects
to ensure a good quality of life for patients. The carefully selected combination
of therapeutic interventions provides patients with the opportunity to derive
maximum benefit from therapy while minimizing or eliminating recurrence, resistance
and toxic effects, as well as ensuring that patients have a good quality of
life. This review discusses therapeutic options for breast cancer treatments and
various combinations that had been previously exploited. The review will also give
an insight into the potential application of the nanotechnology platform for codelivery
of therapeutics in breast cancer therapy.
Publisher
Bentham Science Publishers Ltd.
Subject
Biomedical Engineering,Pharmaceutical Science
Cited by
212 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献